The hypoxia-inducible factor 1α (HIF1-α, encoded by HIF1A), the primary target of this complex, regulates over 80 genes associated with tumor progression, glycolysis, angiogenesis, and metastasis and is negatively regulated by the VHL elongin BC complex [24, 25]. This evidence concerns the gene HIF1A and breast cancer.